FDA Approves Invermectin Lotion for Head Lice
October 28, 2020 04:00pm
By Sara Karlovitch, Assistant Editor
The new mobile app gives those with type 2 diabetes accurate insulin doses with an â€œon-the-goâ€ convenience.
The FDA has just given 501(k) clearance to the first insulin-management and insulin-titration mobile phone app that is compatible with all insulin regimens and connectable to any cloud-connected blood glucose meter.
Developed by digital insulin management company, Hygieia, the app is able to measure individualized doses for all types of insulin regimens and connect to any glucose meter that shares data with the cloud. It is available for both iOS and Android mobile phones.
The app is a portion of Hygieia’s d-Nav Insulin Guidance Service, which combines smart cloud-based technology and a small team of health care professionals to support primary care providers and ultimately help improve the health of those living with type 2 diabetes through accurate glycemic control. The service has been able to substantially reduce cost for at least 6 years, while also demonstrating a long-term ability to aid those with type 2 diabetes in sustaining hemoglobin A1c (HbA1c) reductions.
By using insulin-titration algorithms combined with a patient’s individual blood glucose readings, the service provides personalized insulin adjustments. The mobile phone app brings that information to the forefront, as patients can enter glucose event data into the app to receive a recommended insulin dose.
Also available in Northern Ireland, the d-Nav Service is being offered in the United States by Blue Cross Blue Shield of Michigan (BCBSM). It is available at no cost and with no copays to BCBSM members with type 2 diabetes in its fully insured commercial plans, starting with at-risk populations in Southeast Michigan.